Rapid production of monoclonal antibodies

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/00 (2006.01) A01K 67/027 (2006.01) C07K 16/00 (2006.01) C12N 5/10 (2006.01) C12N 5/12 (2006.01) C12N 5/16 (2006.01) C12N 15/00 (2006.01) C12N 15/13 (2006.01) C12N 15/85 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2438818

The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.

L'invention concerne des hybridomes, des myélomes et des lymphocytes B génétiquement modifiés. Elle a également trait à l'utilisation d'hybridomes, de myélomes et de lymphocytes B génétiquement modifiés dans des procédés de fabrication d'anticorps monoclonaux. L'invention concerne aussi des populations d'hybridomes et de lymphocytes B pouvant être utilisées pour fabriquer un anticorps monoclonal voulu.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Rapid production of monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rapid production of monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid production of monoclonal antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1754723

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.